Skip to main content
TipRanks
Go Ultimate75% OFF

Ascendis Pharma (ASND) Revenue

788 Followers

Ascendis Pharma Revenue

Ascendis Pharma had a revenue of 344.90M in the quarter ending Jun 30, 2026, with 37.60%. This bring the company's revenue in the last twelve months to 1.05B, Increased 21.54%. In the fiscal year ending Dec 31, 2025, Ascendis Pharma had annual revenue of 691.71M with 90.22% growth.

Revenue (ttm)
1.05B
Revenue Growth
128.41%
P/S Ratio
23.14
Revenue/Employee
$581,758
Employees
1,189
Market Cap
$16.01B

Revenue Chart

Ascendis Pharma Revenue - Annual

0200M400M600M800M1.53M10.58M13.38M6.95M7.78M51.17M266.72M363.64M691.71M201720182019202020212022202320242025
Revenue History
Download to Excel
ASND revenue history
Fiscal End DateRevenueChangeGrowth
Dec 31, 2025691.71M328.07M90.22%
Dec 31, 2024363.64M96.92M36.34%
Dec 31, 2023266.72M215.54M421.20%
Dec 31, 202251.17M43.40M557.93%
Dec 31, 20217.78M825.00K11.87%
Dec 31, 20206.95M-6.42M-48.01%
Dec 31, 201913.38M2.79M26.41%
Dec 31, 201810.58M9.05M591.57%
Dec 31, 20171.53M――
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Related Stocks

Related stocks
CompanyRevenue
ASND1.05B
BMRN3.66B
RARE730.00M
XERS368.26M
MBX0.00